Novavax | 资产

股票价格

9.47

每天变化

-0.64 -6.33%

每月一次

14.51%

每年

23.31%

Q1 预测

9.83

金融业

USD

USD 1.18B

现金及等价物

USD 268.02M

USD 60.62M

USD 974.59M

USD 429.87M

USD 233.31M

USD -134.02M

USD -117.12M

1.54K

EPS每股收益

USD -0.76

股本和储备

USD -156.67M

USD 23.89M

债务利息支出

USD 4.24M

USD 303K

USD 223.63M

USD 1.41B

USD -121.3M

USD 218.53M

USD -134.02M

普通股股本

USD 1.62M

2.28

USD -122.33M

USD 84.51M

销售和管理费用

USD 66.95M

USD 13.51M

贸易债权人

USD 15.23M

应收帐款人

USD 94.96M

	资产	更改		日
Adma Biologics	USD 568.69M		10.31M	2025-09
Agenus	USD 233.89M		48.67M	2025-09
AstraZeneca	USD 114.07B		382M	2025-12
BioCryst Pharmaceuticals	USD 446.42M		10.76M	2025-09
Cassava Sciences	USD 129.73M		5.65M	2025-09
Geron	USD 570.54M		3.16M	2025-12
GlaxoSmithKline	GBP 61.12B		221M	2025-12
MannKind	USD 792.18M		297.54M	2025-12
Merck	USD 129.55B		12.02B	2025-09
Minerva Neurosciences	USD 28.09M		2.33M	2025-09
Moderna	USD 12.34B		203M	2025-12
Novartis	USD 107.29B		2.89B	2025-09
Novavax	USD 1.18B		156.66M	2025-09
Pfizer	USD 208.73B		2.64B	2025-09
Sanofi	EUR 126.81B		2.99B	2025-12
Sarepta Therapeutics	USD 3.35B		143.73M	2025-12
TG Therapeutics	USD 1.06B		38.23M	2025-12

Novavax 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.